CURE GABA-A | Grann Pharmaceuticals mRNA Protein Replacement for GABAARs

CURE GABA-A | Grann Pharmaceuticals: mRNA Protein Replacement for GABAAR Disorders

Date & Time

📅 Friday, September 26th 2025
🕐 1:00 PM PST | 4:00 PM EST

Location

Online Event (Zoom link provided upon registration)

Description

🚨 STOP WHAT YOU’RE DOING 🚨

This is the moment everything we’ve worked for comes down to. We started CURE GABA-A with one mission: to get pre clinical data for treatments relating to GABAAR disorders as quickly and safely as possible. And now, we are finally at the beginning.

Grann Pharmaceuticals has developed an mRNA-based protein replacement therapy for GABRA1 and GABRG2 variants. This therapy is already produced and ready for preclinical testing. With the right support, we can bring it to the FDA and into clinical trials by the end of 2026.

But science alone isn’t enough. We need the community to band together now, fundraising, donating, and spreading the word, to make this therapy a reality for children and families.

Join us for a live Q&A with Tommy Temple, CEO of Grann Pharmaceuticals, as he explains:

• What mRNA protein replacement therapy is
• Why it could be the first treatment for GABAAR disorders
• The FDA pathway and clinical trial timeline
• How YOU can make the difference to bring this to clinic

💙 Together we can move from hope to treatment.

Agenda

• Welcome from CURE GABA-A
• Presentation by Tommy Temple (CEO, Grann Pharmaceuticals)
• Live Q&A session
• Call to Action: How to Fundraise and Donate

Tickets

🎟️ Free – Registration required.
Donations encouraged: https://www.facebook.com/donate/4300256346872932/

or GoFundMe: https://www.gofundme.com/f/lifesaving-gene-therapy-drug

Call to Action

✨ Every donation moves us closer to the first-ever GABAAR clinical trial.
✨ Every fundraiser brings hope to families waiting for answers.

👉 Register now, join the movement, and help us make history.